Website
VCID: 91067
Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Develops potent small molecules based on novel mechanisms and chemistry in the fight to target important cancers.Funding
Funding rounds
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Bloomsbury Bioseed Fund Ltd | Publicly funded seed investor in science research coming out of certain UK universities | United Kingdom |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
RCT BioVentures | The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies | United States |
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
RCT BioVentures | The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies | United States | Initial investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Bloomsbury Bioseed Fund Ltd Publicly funded seed investor in science research coming out of certain UK universities |
+44 (20) 7845-7836 |
Seed |
|
|
Cambridge Research BioVentures Ltd |
+44 (1954) 204-002 |
N/A |
|
|
ET Capital Ltd Venture capital firm |
+44 (1223) 236-632 |
N/A |
|
|
RCT BioVentures The vehicle through which Research Corporation Technologies invests in start-up or early-stage companies |
+1 (310) 824-1700 |
N/A |
|
Xenva Ltd |
N/A |